Published in Women's Health Weekly, March 27th, 1995
Raymond J. Apple et al., from Roche Molecular Systems and the University of New Mexico Cancer Research and Treatment Center, suggest that specific HLA class II haplotypes may influence the immune response to human papillomavirus (HPV) infection and therefore affect the risk of developing invasive cervical carcinoma ("Comparison of Human Leukocyte Antigen DR-DQ Disease Associations Found with Cervical Dysplasia and Invasive Cervical Carcinoma," Journal of the National Cancer Institute, March 15,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly